Waters Corp(WAT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 101.08 | EPS (ttm) | 4 | Insider Own | 0.14% | Shs Outstand | 98.2M | Perf Week | -0.25% |
| Market Cap | 39.77B | Forward P/E | 24.53 | EPS next Y | 13.24% | Insider Trans | -1.52% | Shs Float | 98.1M | Perf Month | -1.69% |
| Enterprise Value | 44.69B | PEG | 2.06 | EPS next Q | 4 | Inst Own | 102.18% | Short Float | 3.71% | Perf Quarter | 9.07% |
| Income | 0.17B | P/S | 8.56 | EPS this Y | 10.99% | Inst Trans | 1.31% | Short Ratio | 4.36 | Perf Half Y | 35.1% |
| Sales | 4.64B | P/B | 2.62 | EPS next 5Y | 11.89% | ROA | 1.13% | Short Interest | 3.64M | Perf YTD | 6.58% |
| Book/sh | 154.7 | P/C | 73.79 | EPS past 3/5Y | -2.83% 5.19% | ROE | 1.91% | 52W High | -5.02% ($426.22) | Perf Year | 34.7% |
| Cash/sh | 5.49 | P/FCF | 106.02 | Sales past 3/5Y | 2.12% 6% | ROIC | 0.81% | 52W Low | 43.16% ($282.77) | Perf 3Y | 53.59% |
| Dividend Est. | - | EV/EBITDA | 38.43 | EPS Y/Y TTM | -63.86% | Gross Margin | 41.95% | Volatility(W/M) | 3.14% 2.81% | Perf 5Y | -4.08% |
| Dividend TTM | - | EV/Sales | 9.62 | Sales Y/Y TTM | 52.47% | Oper. Margin | 11.83% | ATR (14) | 12.13 | Perf 10Y | 167.86% |
| Dividend Ex-Date | - | Quick Ratio | 1.29 | EPS Q/Q | -156.16% | Profit Margin | 3.58% | RSI (14) | 50.15 | Recom | 1.86 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.86 | Sales Q/Q | 113.27% | SMA20 | -1.51% ($411.02) | Beta | 1.16 | Target Price | $446.78 |
| Payout | - | Debt/Eq | 0.36 | Earnings | 2026/8/4 | SMA50 | 3.01% ($392.98) | Rel Volume | 0.9 | Prev Close | $402.91 |
| Employees | 7900 | LT Debt/Eq | 0.34 | EPS/Sales Surpr. | 1.32% 1.4% | SMA200 | 12.12% ($361.05) | Avg Volume(3M) | 0.83M | Price | $404.81 |
| IPO | 1995/11/17 | Option/Short | Yes/Yes | Trades | 13917 | Volume | 751,342 | Change | 0.47% |
Company
WAT is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🧪 A global analytical science company that supplies analytical instrumentation such as liquid chromatography and mass spectrometry, along with precision chemical consumables. Founded in 1958 and headquartered in Massachusetts, USA, it is regarded as a high-quality analytical instrumentation stock holding a global leading position in the high-performance liquid chromatography field.
Over the past 1 year, on the higher side
5% below its 1-year high.
WAT makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.0% this year.
Tap to view numbers
The price looks about right
Trading at 101.1 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +53.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 102.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
PHO 0.08%
FIW 0.05%
PIO 0.04%
TMFM 0.04%
EQTY 0.03%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
PHO 2.0B FIW 1.8B
CGW 1.0B PIO 269M
TBLU 56MIt ranks #4 in the industry
Based on market cap of $40B.
WAT $40B PER 101.1
TMO $224B PER 32.6
DHR $144B PER 36.4
NTRA $48B PER -
FAQ
What kind of company is WAT?
WAT belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of WAT?
The market cap of WAT is approximately $39.8B, ranking 388 within its sector.
What is the P/E ratio of WAT?
WAT has a P/E ratio of approximately 101.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WAT?
WAT has recorded a 52-week high of $426.22 and a low of $282.77.
